-
Featured Press Release
Aspira Women’s Health Reports First Quarter 2021 Financial Results
Learn More -
Press Release
Aspira Women’s Health to Reveal 3rd Generation Ovarian Cancer Risk Assessment Technology at ASCO 2021
Learn More -
Press Release
Aspira Women’s Health Initiates Prospective Clinical Study for Benign Risk Monitoring and High Risk Early Ovarian Cancer Detection with Northwell Health®
Learn More
Press Release
Choose a Category:
-
Aspira Women’s Health Reports First Quarter 2021 Financial Results
Press Release
Conference call scheduled for today, May13 at 4:30 p.m. ET For a PDF of this press release, click here. AUSTIN, Texas — May 13, 2021 — Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on gynecologic disease, today reported its financial results for the first quarter ended, March 31, 2021. “We…
-
Aspira Women’s Health to Reveal 3rd Generation Ovarian Cancer Risk Assessment Technology at ASCO 2021
Press Release
For a PDF of this press release, click here. Analytical and Initial Clinical Validation performance for Aspira’s OVASightTM blood-based biomarker test for Ovarian Malignancy risk assessment in women with Adnexal Masses. Data demonstrates the ability to identify Ovarian Cancer Risk in a low prevalence population. AUSTIN, Texas; May 13, 2021 – Aspira Women’s Health, Inc. (Nasdaq:…
-
Aspira Women’s Health Initiates Prospective Clinical Study for Benign Risk Monitoring and High Risk Early Ovarian Cancer Detection with Northwell Health®
Press Release
For a PDF version of this press release, click here. Study Evaluates a 3rd Generation Multivariate Index Assay for serial monitoring women with a benign pelvic mass as well as the expansion of our development of our proteogenomic test for early-stage detection of ovarian cancer in high risk Ovarian Cancer patients. AUSTIN, Texas; May 12, 2021 –…
-
Aspira Women’s Health, Inc. Expands Leadership Team with Industry Veteran
Press Release
For a PDF of this press release, click here. New Team Addition Is a Thought Leader in Reimbursement and Diagnostics AUSTIN, Texas — May 11, 2021 — Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced the appointment of a new member to its leadership team, Greg Richard. Greg Richard…
-
Aspira Women’s Health Inc. to Report First Quarter 2021 Financial Results on May 13
Press Release
For a PDF of this press release, click here. AUSTIN, Texas — May 5, 2021 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that it will report financial results for the first quarter ended March 31, 2021 on Thursday, May 13, 2021, after the market close, followed by an…